Dimethyl Fumarate DR Presolicitation

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-21-R-0102

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
The Defense Logistics Agency (DLA) Troop Support has announced a forthcoming solicitation for a national requirements contract to supply Dimethyl Fumarate Delayed Release (DR) capsules. This presolicitation notice, identified under procurement number SPE2D2-21-R-0102, outlines the agency’s intent to establish a reliable, long-term source of supply for these pharmaceutical products, which are critical to Department of Defense (DoD) healthcare operations. The scope of this procurement encompasses two specific formulations: Dimethyl Fumarate DR 120mg capsules packaged in 14-count bottles, and Dimethyl Fumarate DR 240mg capsules in 60-count bottles. The contract will be structured as a firm-fixed price, requirements-type agreement, featuring a one-year base period with the possibility of four additional one-year option periods. This arrangement is designed to ensure consistent, nationwide availability of the specified items for DoD customers, facilitated through the DLA prime vendor program. This acquisition is classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), with a Product Service Code of 6505, indicating its focus on pharmaceutical products. The procurement is designated as unrestricted and fully competitive, inviting proposals from all qualified sources. The solicitation will be conducted in accordance with Federal Acquisition Regulation (FAR) Part 12, which governs the acquisition of commercial items, and will adhere to the requirements clause at FAR 52.216-21. The contract will serve as a national supply source, and annual usage estimates for each item will be detailed in the Schedule of Supplies section of the forthcoming solicitation. Interested contractors should note that this opportunity does not include any set-aside provisions; all capable suppliers are encouraged to participate. The DLA will post the official solicitation on both the DLA Bid Board System (DIBBS) and SAM.gov, and parties are encouraged to register for automated notifications regarding updates or changes to the solicitation. The anticipated release date for the solicitation is February 2021, though DLA reserves the right to adjust this timeline as necessary. For further information or to address any questions, interested parties should contact Kevin Rafferty at DLA Troop Support via email at [email protected] or by phone at 215-737-0907. The notice remains active as of its posting date, August 10, 2024, and all relevant documentation and updates will be accessible through the provided SAM.gov opportunity link. This procurement represents a significant opportunity for manufacturers and suppliers of pharmaceutical preparations, particularly those with the capacity to meet national demand for Dimethyl Fumarate DR capsules under a long-term, requirements-based contract with the federal government.
Documents6